An additional advantage of GSH is that it helps in maintaining and fostering HFF-1 cell confluence while significantly inhibiting MRAB adhesion, colonization and HFF-1 infection (Figure 7)
Which claims rest on human trials, which rest on rat studies, and what is unsafe.
Specifically, in the group of patients prescribed semaglutide for weight loss, 6.7% developed NAION compared to just 0.8% of those on other treatments
The disconnect between the population prevalence of obesity and care utilization is driven by a range of factors such as stigma and discrimination in healthcare settings, lack of educational and cultural training among physicians on how to address this issue with patients, and the cost of treatment
Case reports exist of palpitations and faster heart rate, and postmarketing data include rare arrhythmia reports, so clinicians weigh pulse changes against cardiovascular risk reduction seen in many trial populations
Side effects may last for weeks after the last dose is taken